Vagal nerve stimulation (VNS) is one of the neuromodulation techniques that can be indicated in patients suffering from refractory epilepsies, especially when an open resection has failed or is not indicated. However to date it is not possible to predict which patients will respond and what are the best parameters of stimulation to be set (pulse width, frequency and intensity). It has been shown that responders to VNS have reduced interictal cortical synchronicity on scalp EEG based on phase lag index (PLI), a marker of functional connectivity (Fc) The aim of this study is to test the following hypothesis: setting the parameters of stimulation on the basis of the lowest values of Phase Lag Index (PLI) obtained on scalp EEG with different settings of parameters (as compared with a randomly chosen set of commonly used parameters) will increase the rate of responders to VNS.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
140
Vagal nerve stimulation according to PLI results.
Patient will have an EEG and 12 sets of parameters will be tested. EEG results will be analyzed which will allow to determine the set involving the lowest phase lag index.
Department of functional explorations of the nervous system, CHU
Amiens, France, France
Neuropediatrics department, CHU Angers
Angers, France, France
Neurology Department, CHU Bordeaux
Bordeaux, France, France
Clinical neurophysiology, CHU Dijon
Dijon, France, France
Epilepsy neurophysiopathology department, CHU Grenoble
Grenoble, France, France
Clinical neurophysiology, CHU Lille
Lille, France, France
HCL Lyon
Lyon, France, France
Department of clinical neurophysiology, Hôpital La Timone, APHM
Marseille, France, France
Neurosurgery Department, CHRU Nancy
Nancy, France, France
Neurosurgery Department, CHU Nantes
Nantes, France, France
...and 8 more locations
Mean number of seizures per month
Time frame: Change from baseline to 6 months
Mean number of seizures per month
Time frame: Change from baseline to 12 months
Number of responders in each group
Time frame: Change from baseline to 6 months
Number of responders in each group
Time frame: Change from baseline to 12 months
Number of generalized seizures
Time frame: Change from baseline to 6 months
Number of generalized seizures
Time frame: Change from baseline to 12 months
Number of seizures with falls
Time frame: Change from baseline to 6 months
Number of seizures with falls
Time frame: Change from baseline to 12 months
Number of seizures with alteration of consciousness
Time frame: Change from baseline to 6 months
Number of seizures with alteration of consciousness
Time frame: Change from baseline to 12 months
Score of depression
NDDI-E
Time frame: Change from baseline to 6 months
Score of depression
NDDI-E
Time frame: Change from baseline to 12 months
Score of anxiety
GAD-7
Time frame: Change from baseline to 6 months
Score of anxiety
GAD-7
Time frame: Change from baseline to 12 months
Score of quality of life
QUOLIE 31
Time frame: Change from baseline to 6 months
Score of quality of life
QUOLIE 31
Time frame: Change from baseline to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.